What is Tirzepatide and What Does it Do?
The Short Answer: Tirzepatide is a dual-action injectable medication that simultaneously targets two metabolic hormone receptors (GIP and GLP-1) to […]
The Short Answer: Tirzepatide is a dual-action injectable medication that simultaneously targets two metabolic hormone receptors (GIP and GLP-1) to […]
The Short Answer: Tirzepatide promotes weight loss through a dual-hormone mechanism that suppresses appetite, slows gastric emptying, and improves insulin […]
The Short Answer: Yes. The FDA approved tirzepatide for chronic weight management on November 8, 2023, under the brand name […]
The Short Answer: Tirzepatide currently holds FDA approval for two conditions: type 2 diabetes (as Mounjaro) and chronic weight management […]
The Short Answer: Yes. Tirzepatide is the active pharmaceutical ingredient, while Mounjaro is Eli Lilly’s brand name for the same […]
The Short Answer: Tirzepatide activates two hormone receptors (GIP and GLP-1) while semaglutide activates only one (GLP-1). This dual mechanism […]